Breaking: ‘WHO’ accepts Bharat Biotech’s Covaxin for emergency use listing


Guwahati: The World Health Organisation (WHO) has finally approved Bharat Biotech’s Covaxin for emergency usage.

The technical committee of World Health Organization (WHO) met on Wednesday to discuss the issue of giving Emergency Use Listing (EUL) to made in India Covid-19 vaccine Covaxin. 

Earlier, the committee had on October 26 sought additional clarifications from Covaxin manufacturer Bharat Biotech.

Before approving Covaxin, the WHO has approved six vaccines – Pfizer/BioNTech’s Comirnaty, AstraZeneca’s Covishield, Johnson & Johnson’s vaccine, Moderna’s mRNA-1273, Sinopharm’s BBIBP-CorV and Sinovac’s CoronaVac.

The other countries which have already given approval to Covaxin to ease international travel and allow passengers to enter their geographies. These are:

• Guyana

• Iran

• Mauritius

• Mexico

• Nepal

• Paraguay

• Philippines

• Zimbabwe

• Australia